Danaher Corporation (NYSE:DHR – Get Free Report) has earned an average recommendation of “Moderate Buy” from the twenty-five analysts that are presently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, four have given a hold recommendation, nineteen have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $233.5217.
DHR has been the subject of several research reports. Evercore reiterated an “outperform” rating and issued a $230.00 target price on shares of Danaher in a research report on Monday. HSBC reduced their price objective on Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research note on Wednesday, June 3rd. JPMorgan Chase & Co. lowered their target price on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. Jefferies Financial Group restated a “buy” rating and issued a $245.00 price target on shares of Danaher in a research report on Tuesday, April 21st. Finally, Barclays decreased their price target on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a report on Tuesday, April 14th.
View Our Latest Report on Danaher
Institutional Trading of Danaher
Danaher Price Performance
DHR opened at $190.90 on Thursday. The company has a 50-day moving average of $179.85 and a 200-day moving average of $199.68. The company has a market capitalization of $135.11 billion, a P/E ratio of 36.92, a PEG ratio of 2.48 and a beta of 0.79. Danaher has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87.
Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping the consensus estimate of $1.94 by $0.12. The business had revenue of $5.95 billion for the quarter, compared to analysts’ expectations of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The company’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same quarter last year, the company posted $1.88 earnings per share. Equities analysts expect that Danaher will post 8.44 EPS for the current fiscal year.
Danaher Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Friday, June 26th. Danaher’s payout ratio is presently 30.95%.
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Articles
- Five stocks we like better than Danaher
- A Market Panic Just Discounted the AI Highway’s Tollbooth
- Why Exxon Could Be the Market’s Next Big Comeback Stock
- The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
- Meta Platforms’ Cloud Push: Growth Opportunity Versus AI Concerns
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
